The CD105:CD106 microparticle ratio is CD106 dominant in polycystic ovary syndrome compared to type 2 diabetes and healthy subjects

• Published in: Endocrine Vol. 66; no. 2; pp. 220 - 225
• Main Authors: Al-Qaissi, Ahmed, Alqarni, Saeed, Javed, Zeeshan, Atkin, Stephen L., Sathyapalan, Thozhukat, Vince, Rebecca V., Madden, Leigh A.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.11.2019; Springer Nature B.V
• Subjects: Adult; Biomarkers - blood; CD105 antigen; Cell adhesion & migration; Cell adhesion molecules; Cell-Derived Microparticles - metabolism; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - metabolism; Endocrinology; Endoglin; Endoglin - metabolism; Female; Flow cytometry; Humanities and Social Sciences; Humans; Intercellular adhesion molecule 1; Intercellular Adhesion Molecule-1 - blood; Internal Medicine; Medicine; Medicine & Public Health; Microparticles; multidisciplinary; Original; Original Article; Polycystic ovary syndrome; Polycystic Ovary Syndrome - metabolism; Retrospective Studies; Risk Factors; Science; Vascular cell adhesion molecule 1; Vascular Cell Adhesion Molecule-1 - metabolism; Young Adult; Polycystic ovary syndrome; VCAM-1; Endothelial microparticles

Background A retrospective analysis was carried out from patients and controls during the past 5 years from a series of studies investigating endothelial microparticles (MP). Methods In total, 319 samples from 207 individuals were included in this analysis, from patients with type 2 diabetes (T2D, n...